Many patients with atrial fibrillation are not taking oral anticoagulation because of an elevated bleeding risk, and this subset faces substantial risks of both ischemic and hemorrhagic stroke, a new ...

Please provide your email address to receive an email when new articles are posted on . Older patients with atrial fibrillation were more likely to have high bleeding risk contraindications with oral ...

Atrial fibrillation patients with mental health conditions are less likely to be eligible for warfarin receipt, and those who are eligible receive warfarin at lower rates. Objectives: To characterize ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio Patients with venous thromboembolism and ...

Atrial fibrillation (AF) greatly increases the risk ofstroke. Long-term oral therapy with warfarin reducesthe risk of AF-related stroke by 62%, and nationalguidelines now call for warfarin therapy in ...

The overall risk of stroke in patients with PAF is thought to be comparable to that of patients with chronic persistent A Fib. [1,2,3] As a result, consensus guidelines favor a similar decision-making ...

Purpose. The effectiveness of a program to improve adherence to best-practice guidelines for venous thromboembolism (VTE) risk assessment and prevention in a community hospital setting was evaluated.

In a population largely consisting of patients with nonvalvular A-fib who have contraindications to warfarin therapy, implantation of the Watchman left atrial appendage (LAA) closure device appears ...

Atrial fibrillation (AF) is a major risk factor for disabling ischemic strokes. Anticoagulation is highly effective for stroke prevention in patients with AF, but a substantial number of patients are ...

HealthDay News — Clinical practice guidelines for anticoagulation therapy for cardiopulmonary bypass (CPB) have been developed and were published in the February issue of the Annals of Thoracic ...

Most patients with pulmonary embolism (i.e., low-risk, intermediate–low-risk, and most intermediate–high-risk) are adequately managed with anticoagulation alone. Selected intermediate–high-risk ...

Comparison of Subcutaneous Versus Intravenous Administration of Rituximab As Maintenance Treatment for Follicular Lymphoma: Results From a Two-Stage, Phase IB Study A total of 775 patients with cancer ...